Well-being

Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial

Retrieved on: 
Thursday, November 17, 2022
Research, General Health, Professional Services, Pharmaceutical, Small Business, Clinical Trials, Science, Biotechnology, Alternative Medicine, Finance, Other Science, Health, ASD, CSE, Nova, Clinical trial, Autism, Protocol, OTC, FXS, KGK, Drug development, NOVA, Patient, FRA, Well-being, Research, Phase II, SQ2, MEDI, Fragile X syndrome, Therapy, Digital Science, Data management, Psilocybin, Database, NEO, Publication, Pharmaceutical industry

The pioneering Phase II clinical trial is the first human research investigating the potential of a microdose of psilocybin to improve behavioural and cognitive symptoms associated with Fragile X syndrome.

Key Points: 
  • The pioneering Phase II clinical trial is the first human research investigating the potential of a microdose of psilocybin to improve behavioural and cognitive symptoms associated with Fragile X syndrome.
  • Under the research and services agreement with Nova Mentis, KGK will perform research services, including the development of the clinical trial protocol, regulatory and ethics submissions, conduct of the trial, data management and validation, statistical analysis and drafting of the final report (Services).
  • The clinical trial is planned to be conducted at KGKs dedicated research facility in London, Ontario, Canada.
  • Subsidiary of Wellbeing Digital Sciences, KGK is a leading North American contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on nutraceutical and emerging health care products.

Signia Styletto AX and New Augmented Xperience (AX) Platform Capabilities are Now Available to Veterans, Active Military Members, and Native Americans -- Delivering the Freedom to Experience Optimized Hearing and Improved Health and Wellness

Retrieved on: 
Tuesday, November 1, 2022
Awareness, Hearing, U.S. Department of Veterans Affairs, Office of Inspector General, Freedom, Health, Audiology, Color, Kool-Aid, U.S. Department of Defense Strategy for Operating in Cyberspace, Government, Indian Health Service, Native Americans, Speech, United States Department of Defense, IPad, Hearing loss, AX, Bluetooth, Socialization, Health care, IPhone, Well-being, Discovery Air, IHS, Movement, Public relations, Real estate, Signia, Veteran

PISCATAWAY, N.J., Nov. 1, 2022 /PRNewswire/ -- Hearing aid innovator Signia today announced its new Styletto AX hearing aid and two new capabilities for its Augmented Xperience (AX) platform — My WellBeing and CallControl — are now available to military veterans through the U.S. Department of Veterans Affairs (VA) audiologists, as well as audiologists within the U.S. Department of Defense (DoD), for active military members and the Indian Health Service (IHS) for Native Americans.

Key Points: 
  • Launched in September 2022, Styletto AX features the world's first SLIM-RIC hearing aid with a slim and stylish design that breaks down stigma.
  • "Signia recognizes that many of our country's veterans have hearing loss related to the contributions they made to secure our freedom.
  • "With Styletto AX, we're furthering our commitment to delivering innovative solutions and unparalleled support to veterans, active military and Native Americans."
  • With CallControl, veterans can use their Signia AX hearing aids to operate the Signia HandsFree feature with their iPhones or iPads via Bluetooth.

Wellbeing Announces Definitive Agreement to Divest IRP Health

Retrieved on: 
Thursday, October 27, 2022
Biotechnology, Alternative Medicine, Professional Services, Health, General Health, Small Business, Mental Health, Other Science, Research, Science, Finance, Health, OTC, Chronic pain, Nursing, Cannabis Act, NEO, MEDI, Pain, Well-being, IRP, Pharmacy, Person-centered therapy, Patient, RCMP, Education in Toronto, CEO, United States Public Health Service, Drug development, Intellectual property, FRA, Pathway, Therapy, SQ2, Pharmaceutical industry

Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that it has entered into a definitive agreement (Agreement) under which Pathway Health Corp. (Pathway) will acquire all or substantially all of the operating assets of Wellbeings subsidiary IRP Health Ltd. (IRP).

Key Points: 
  • Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that it has entered into a definitive agreement (Agreement) under which Pathway Health Corp. (Pathway) will acquire all or substantially all of the operating assets of Wellbeings subsidiary IRP Health Ltd. (IRP).
  • Pathway will assume the lease and all of the assets in the Victoria, British Columbia location, including all intangible assets, prepaid expenses, deposits, and equipment.
  • "This agreement generates additional value for Wellbeing shareholders and allows Wellbeing to focus on expanding our clinical network footprint to treat mental health indications with novel medicines in conjunction with digital therapeutics.
  • We're very pleased to be entering into this agreement with Wellbeing and IRP as we look to expand our pain, allied health/rehabilitation, and mental health services to our military veterans, RCMP and other first responders," said Ken Yoon, CEO at Pathway.

Żabka Group is looking for startups aiming to make a positive impact on their environment

Retrieved on: 
Monday, October 10, 2022
Biophysical environment, Kozminski University, Communication, Risk, Ecology, Employment, Plastic, Carbon, Mental health, Multimedia, Doctor of Philosophy, Health, Group, Ecosystem, Well-being, Environment, Entrepreneurship, Solution

The Startup Impact Program is addressed to young businesses with a goal to make a positive impact on their environment, i.e., active in the field of ecology, health and entrepreneurship.

Key Points: 
  • The Startup Impact Program is addressed to young businesses with a goal to make a positive impact on their environment, i.e., active in the field of ecology, health and entrepreneurship.
  • The creators that make it to the finals of the second edition of the programme, will be invited for further cooperation with experts from the Kozminski Business Hub and abka Group.
  • "We are looking for innovative solutions with new development prospects for the whole abka Group.
  • Startups singled out in the programme will receive collectively developed detailed impact reports, which will surely attract impact investors.

Żabka Group is looking for startups aiming to make a positive impact on their environment

Retrieved on: 
Monday, October 10, 2022
Biophysical environment, Kozminski University, Communication, Risk, Ecology, Employment, Plastic, Carbon, Mental health, Doctor of Philosophy, Health, Group, Ecosystem, Well-being, Environment, Entrepreneurship, Solution

The Startup Impact Program is addressed to young businesses with a goal to make a positive impact on their environment, i.e., active in the field of ecology, health and entrepreneurship.

Key Points: 
  • The Startup Impact Program is addressed to young businesses with a goal to make a positive impact on their environment, i.e., active in the field of ecology, health and entrepreneurship.
  • The creators that make it to the finals of the second edition of the programme, will be invited for further cooperation with experts from the Kozminski Business Hub and abka Group.
  • "We are looking for innovative solutions with new development prospects for the whole abka Group.
  • Startups singled out in the programme will receive collectively developed detailed impact reports, which will surely attract impact investors.

Wellbeing Digital Signs LOI Manage Additional Clinics

Retrieved on: 
Tuesday, October 4, 2022
Mental Health, Research, Clinical Trials, Practice Management, Alternative Medicine, Managed Care, Health, Pharmaceutical, Science, OTC, NEO, Science, Drug development, FRA, Research, Clinical trial, CEO, Well-being, MD, SQ2, Growth, RTM, Partnership, Pain management, Dietary supplement, MEDI, Patient, LOI, Mental health, Therapy, Pharmaceutical industry

Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that it has entered into an agreement to manage three additional clinics and accelerate the clinics growth efforts.

Key Points: 
  • Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that it has entered into an agreement to manage three additional clinics and accelerate the clinics growth efforts.
  • Through this agreement, formalized with a Signed Letter of Intent (LOI), Wellbeing will be rolling in 3 additional clinics into the Companys clinical ecosystem, supporting the continued focus on increasing Wellbeings North American clinical footprint strategy.
  • Under proposed agreement the clinics under Wellbeing management will provide IV Ketamine therapy, clinical trial management and site support for psychedelic medicines, dietary supplements and other natural medicines.
  • Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research.

Wellbeing Digital to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics

Retrieved on: 
Thursday, September 29, 2022
Pharmaceutical, Health, Clinical Trials, Mental Health, Therapy, FRA, MEDI, Psychotherapy, Well-being, Growth, Patient, Mental health, OTC, CEO, NEO, Drug development, SQ2, Pharmaceutical industry

Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate in the Cantor Fitzgerald Mental Health Clinics Symposium to be held virtually on October 11, 2022 at 9:00 a.m.

Key Points: 
  • Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate in the Cantor Fitzgerald Mental Health Clinics Symposium to be held virtually on October 11, 2022 at 9:00 a.m.
  • Najla Guthrie will take part in a 45 minute fireside chat discussing the mental health clinics industry in North America and their significant growth, transformation, and consolidation.
  • For more information about the conference, or to schedule a one-on-one meeting with Wellbeings management team, please send an email to Natalie Dolphin at [email protected] .
  • Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research.

HMA conference to look at future of Hospital at Home model in Asia

Retrieved on: 
Wednesday, September 28, 2022
Traction, Epworth HealthCare, Department, Department of Medicine – University of Pamplona, Health, Philips, NUHS, Hospital, Founder CEO, Ministry, Well-being, Ministry of Health (Singapore), Lafayette Home Hospital, Division, Dr. Jeyasekharan Hospital & Nursing Home, Senior, Singapore General Hospital, Heart failure, Hah, Patient, Medical home, CEO, Program director, Solution, Technology, Consultant, Caregiver, Mobile, MIC, MOH, FMCC, Health insurance, Medical device

This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.

Key Points: 
  • This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.
  • The one-day event on 25 November will delve into different aspects of hospital at home programmes with a particular focus on Singapore's MIC@Home (Mobile Inpatient Care at Home).
  • Prof Dan and Dr Montalto will be joining the first panel discussion looking at whether Hospital at Home is the future of acute medicine.
  • Registration is now open - click on this link for more information on the agenda, speakers, and to register: www.hospitalmanagementasia.com/events/hospital-at-home/.

Signia launches My WellBeing tool to promote a more active lifestyle while encouraging consistent use of hearing aids

Retrieved on: 
Tuesday, September 13, 2022
Steps, Hearing, Health, Profile, IOS, Risk, Prevalence, Well-being, Social isolation, Hearing loss, Falls, Patient, Android, Dementia, GLOBE, Kool-Aid, Distress, Depression, Personal protective equipment, Medical device, Signia

TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Hearing aid innovator Signia is launching My WellBeing, a new app-based toolset designed to improve the hearing health of Signia hearing aid wearers by encouraging a more consistent and prolonged use of their hearing devices.

Key Points: 
  • TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Hearing aid innovator Signia is launching My WellBeing, a new app-based toolset designed to improve the hearing health of Signia hearing aid wearers by encouraging a more consistent and prolonged use of their hearing devices.
  • The tool, available through the Signia app, offers four features that help wearers stay motivated to remain physically active and engage in social interactions while wearing their hearing aids.
  • In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management.
  • Signia, and its hearing care professionals, enable hearing aid wearers to not just correct hearing loss but to gain an edge to Be Brilliant.

Signia Launches Styletto AX, a Breakthrough Hearing Aid That Features An Award-Winning Form-Factor and New Augmented Xperience (AX) Platform Capabilities That Further Optimize Health & Wellness

Retrieved on: 
Tuesday, September 6, 2022
Steps, Android, Slim, Technology, IPhone, Awareness, Music, Well-being, Overalls, Bluetooth, IPad, Hearing, Freedom, Speech, IOS, Color, Kool-Aid, Doctor of Audiology, Hearing loss, Marketing, Hearing aid, Health, AX, Personal protective equipment, Mobile phone, Pharmaceutical industry, Signia

PISCATAWAY, N.J., Sept. 6, 2022 /PRNewswire/ -- Furthering its mission to provide consumers with best-in-class hearing aid technology in sleek and modern form-factors, hearing aid innovator Signia today launched Styletto AX, a new hearing aid featuring two new capabilities for its Augmented Xperience (AX) platform – My WellBeing and CallControl. These new features help consumers lead healthier lifestyles through dramatically enhanced hearing and overall wellness.

Key Points: 
  • First introduced in 2018, Signia's Styletto is the world's first Slim Receiver-in-Canal (SLIM-RIC) hearing aid that features a slim and stylish design that breaks down stigma.
  • "Today's hearing aid wearers increasingly demand both cutting-edge functionality and premium, stylish design," said Jennifer Wright, AuD, Vice President of Marketing at Signia.
  • CallControl allows Signia AX hearing aid wearers to operate the Signia HandsFree feature with their iPhone or iPad.
  • Signia, and its hearing care professionals, enable hearing aid wearers to not just correct hearing loss but to gain an edge to Be Brilliant.